Industry Watch: New Research Bolsters Kratom's Potential, Aids Long-Term Advocacy
A recent University of Houston study found that a combination of mitragynine and naltrexone significantly reduced alcohol use in rats, reinforcing kratom's potential therapeutic applications. While positive for long-term industry legitimacy, this research does not trigger immediate changes to legal status, payment processing, or shipping for merchants.
A new study from University of Houston researchers, conducted on alcohol-self-administering female Sprague Dawley rats, found that a combination of mitragynine and naltrexone decreased alcohol use more effectively than either substance alone. This research adds to a growing body of evidence suggesting kratom's potential in addressing alcohol consumption, with previous studies in humans and mice also showing promising results. The article notes that such research is significantly more difficult to conduct in places where kratom is classified as a Schedule I controlled substance, highlighting ongoing hurdles for scientific inquiry.
The 'So What?' for Merchants:
- No immediate changes to kratom's legal status are indicated by this research.
- Payment processing and banking stability for kratom merchants remain unaffected by these findings.
- No new shipping or logistics restrictions are introduced by this study.
Source: Kratom Science via Sentinel Newsroom
Related
- Kratom legal status map
- Latest news & updates
- KratomBans API — checkout validation & compliance for merchants
Get email alerts when kratom laws change in your area.
Email AlertsMerchants: Add legal status to your store →
KRATOMBANSAffiliate relationships do not influence legislative reporting.